Displaying 26–50 of 75 results for Patheon

Sort By Relevance Sort By Date

Learn about Mitigating Risk, Maximizing Compliance in Outsourcing Relationships

(Whitepaper)

This white paper, first in a series of three, is to help executives and managers assigned to provide due-diligence of prospective contract manufacturing partners a framework in which to make a solid, objective evaluation of its overall operational excellence as it relates to quality.

ISPE Panel Names 2014 Facility of the Year Awards

(News)

Winning projects for 2014 were selected from 27 well-qualified entries

State of the Union: Overview

(Article)

Pharmaceutical manufacturing capacity is increasingly global and going biologic, but challenged to meet the realities of cGMP

Completed Patheon and DSM Merger Forms New Powerhouse CMO

(News)

$2.65 billion transaction combines the capabilities and expertise of Patheon and DSM Pharmaceutical Products to create industry powerhouse

QbD Included in DCAT Week '14 Lineup

(News)

DCAT Week '14, held March 10-14 in NYC, will address quality by design in a session titled, Quality by Design: Client, Contractor, and Regulatory Perspectives with Case Studies.

Preventing Filming, Sticking of Cohesive Compounds

(Article)

Inline cooling to reduce temperatures at tablet compression offers relief from this sticky issue.

The Road Ahead for Contract Service Excellence

(Article)

Leading contract service organizations discuss operations and strategies driving success.

WellSpring Pharma Services Expands Business Development Team

(News)

WellSpring appoints Lonnie Barish, MBA, as executive director of business development, and David Watt as technical director, pharma services

DSM Biologics and Australian Plant Included in Patheon Merger

(News)

Royal DSM has confirmed that its biologics manufacturing operations and new Australian facility will be part of the business merged with Patheon in its agreement with JLL.

Asia-Pacific Pearl: DSM's Brisbane Biopharma Facility

(Article)

Clearly articulating its long-term strategic and global interest in biologics, last October DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, officially announced opening of its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, ...

DSM and Patheon Merge to Form $2 Billion Global CDMO Powerhouse

(Article)

Expected 2014 sales of about $2 billion

Royal DSM to Acquire Patheon and Create New, Global CDMO

(News)

The new company anticipates 2014 sales of about $2 billion

Ins & Outs of Tech Transfer

(Article)

Best practices for one of oursourced manufacturing's tougher challenges

Patheon Enters into Agreement to Buy Banner Pharmacaps

(News)

Patheon acquires Banner Pharmacaps to build scale, expand capacity and broaden footprint in emerging markets

Soft Sell: Patheon Introduces P-Gels

(Multimedia)

At Interphex 2012, Patheon's Geoffrey Glass and Softigel's Alvaro Franco discuss their companies' new collaboration to offer customers P-Gels, or prescription softgels and other new technologies that have not previously been available within pharmaceutical contract manufacturing. New, innovative ...

News: Global Pharmaceutical Contract Manufacturing Market to Reach US$40.7 ...

(News)

The global market for pharmaceutical contract manufacturing witnessed robust growth in recent years, and the future continues to hold tremendous prospects for the industry.

Contract Drug Developer Patheon Lets CEO Go, Seeks New Leadership

(News)

Contract drug developer Patheon said Wednesday it has let president and chief executive Wesley Wheeler go. Company chairman Ramsey Frank said Patheon has reached a stage where new leadership is required to realize its full potential. Peter Bigelow, president of Patheon's North American ...

Wyeth's OpEx Legacy

(Blog)

Patheon Signs Deals with Sanofi-Aventis

(News)

Two five-year manufacturing agreements extend the partnership between the two companies.

Pharma’s Green Evolution

(Article)

Big Pharma has gone green, but smaller manufacturers have yet to flip the switch, say industry experts and our own survey.

July/August 2009

July/August 2009

From the Editor: Share the Risk, If You Dare

(Article)

Can the act of quantifying and promising results for customers, and taking a hit if they’re not met, actually improve one’s own performance?

Patheon Puts Its Money Where Its Mouth Is

(Article)

Patheon’s metrics have improved to the point that it is incorporating on-time delivery guarantees and other new wrinkles into its contracts.

Sort By Relevance Sort By Date